Our main findings were that PRSs (beyond the APOE region variant) for AD were associated with higher levels of CSF tau biomarkers (with most substantial effects for comparatively inclusive PRSs) rather than biomarkers of Aβ and neurodegeneration. The gene discussed is APOE; the disease is Alzheimer disease.